Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitche | Eli ...

Novo Nordisk plans to resubmit an application to have Wegovy listed with ... for many Australians who could benefit from them, some form of government-funded access needs to be on the horizon.

Danish weight-loss drug maker Novo Nordisk ... drug in pill form in the U.S. before its top rival in the weight loss category, Eli Lilly (LLY), does so. NVO expects to submit an application ...

Pursuing the world's first-ever orally-dosed liraglutide KELOWNA, BC / / February 20, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW ...

Despite strong Atlas growth, MongoDB must increase enterprise customer share to return to previous growth rates. See why I ...

An investigation by Channel 4 Dispatches has uncovered teenagers can purchase the weight-loss drug Wegovy from high street ...

LEQEMBI (lecanemab) has significant market potential due to the high global prevalence of the condition and the demand for disease-modifying treatmen ...

Lexaria executing a triple-pronged strategy in obesity and diabetesSemaglutide recently approved to treat chronic kidney disease KELOWNA, BC / ACCESS Newswire / February 27, 2025 / Lexaria Bioscience ...

Transitioned lead commercial responsibility of Nuvaxovid COVID-19 vaccine to Sanofi beginning with the 2025-2026 season Achieved total revenue of $88 million in ...

In large patient populations, through our collaboration with Novo Nordisk in metabolic diseases ... we plan to submit an IND application for this basket trial to the U.S. FDA.

Boryung announced on the 18th the launch of 'Ravetricks Capsule', a combination of aspirin and rabeprazole. Ravetricks is a product designed to improve gastrointestinal bleeding that may occur with ...